Form 4: Immix Biopharma CFO Gabriel Morris Reports Stock Purchase

CFO of Immix Biopharma, Gabriel Morris, reports the purchase of 4,500 shares of common stock at $2.2315 per share.

Summary

• On May 14, 2024, Gabriel Morris, the CFO of Immix Biopharma, Inc. [IMMX], purchased 4,500 shares of common stock.
• The purchase price was $2.2315 per share.
• Following the transaction, Mr. Morris directly owns 85,816 shares of Immix Biopharma common stock.
• Mr. Morris also indirectly owns 246,703 shares through Alwaysraise LLC, where he is the Managing Partner and Sole Member.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CFO's purchase of shares is a positive sign, but the transaction is relatively small and may not have a significant impact on the stock price.

Positives

• The CFO's purchase of shares could be interpreted as a positive signal about his confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors often monitor these filings to gain insights into management's sentiment about the company's stock.

Stakeholder Impact

• The stock purchase by a key executive could positively influence investor sentiment.

Key Dates